Table 2 Sites of lesions and SUV_max (¹¹C-Choline and ¹⁸F-FDG) on a lesion by lesion basis. Bold: SUV_max of positive lesions. Non Bold: SUV_max of negative areas.

1

Male

61

IgA/lamda IIIA

Chemotherapy + double autotranspalnt

Post-therapy

19

Clinical follow-up

0

2

Male

55

IgA/lamba IIIA

Chemotherapy + autotranspalnt

Suspect relapse

20

Clinical follow-up

1

2

3

4

5

6

7

8

pleura

soft tissues

humerus

humeral head

soft tissues

Ribs

D11

D12

7.0

4.2

5.1

6.0

3.0

4.7

2.5

2.7

1.0

2.0

1.3

1.9

0.8

1.5

1.0

1.0

3

Male

56

IgA/lamba IIIA

Chemotherapy + autotranspalnt

Post-therapy

8

Whole body X-rays

0

4

Male

72

Solitary plasmacytoma of bones

Radiotherapy

Follow-up

31

Magnetic resonance imaging

9

10

sacrum

D8–D10

5.6

2.0

2.8

1.0

5

Male

62

IgG/K IA

Chemotherapy + autotranspalnt

Follow-up

16

Clinical follow-up

0

6

Female

55

IgG/lamba IIIA

Chemo-radiotherapy

Suspect relapse

16

Clinical follow-up

11

12

13

14

15

16

17

18

19

20

21

skull

scapula

clavicle

humerus

soft tissues

soft tissues

ribs

sternum

pelvis

sacrum

femur

1.3

4.2

2.8

3.6

5.5

4.5

6.5

4.0

7.5

6.0

5.7

3.5

9.7

6.6

4.5

13.7

12.3

6.5

3.0

4.9

5.8

3.1

7

Female

57

IgG/lamba IIIA

Chemotherapy + autotranspalnt

Suspect relapse

16

FDG PET/CT

22

23

24

25

26

27

28

29

30

31

scapula

sternum

clavicle

ribs

D4–D8

L4

L5

pelvis

sacrum

femur

1.3

1.8

2.4

3.0

2.2

2.3

2.2

2.9

1.1

3.0

1.0

3.4

1.2

2.5

1.0

1.7

1.9

0.9

1.6

1.7

8

Male

59

IgG/lamba IA

Chemotherapy

Post-therapy

8

FDG PET/CT

0

9

Female

49

IgA/K IIIA

Chemotherapy + autotranspalnt

Suspect relapse

8

FDG PET/CT

32

33

34

35

36

37

skull

clavicle

scapula

ribs

pelvis

femur

15.0

12.9

7.5

12.4

4.6

19.2

5.8

9.1

2.5

8.5

3.0

7.6

10

Male

53

Solitary plasmacytoma of bones

Radiotherapy

Post-therapy

1

Magnetic resonance imaging

38

sacrum

0.9

4.9

Mean

5.0

3.8

p

0.042